Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
REVENUES:
Revenues	$ (188,597)	$ 117,989
OPERATING EXPENSES:
Cost of products sold	147,840	0
Research and development	12,926,559	13,959,397
Selling, general and administrative	17,336,913	9,765,372
Loss on license termination agreement	2,784,192	0
Total operating expenses	33,195,504	(23,606,780)
Loss from operations	(33,384,101)	(23,606,780)
OTHER INCOME (EXPENSE):
Investment income	23,572	1,200,898
Foreign currency loss	(212,526)	0
Interest expense	(23,440)	(20,141)
Total other income (expense), net	(212,394)	1,180,757
NET (LOSS) INCOME	$ (33,596,495)	$ (22,426,023)
Basic and diluted net income (loss) per common share	$ (.14)	$ (0.10)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	236,650,101	234,684,776
Product Revenue
REVENUES:
Revenues	$ (283,286)	$ 0
License and Contract
REVENUES:
Revenues	$ 94,689	$ 117,989